Correlation Between Cullinan Oncology and Bolt Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Bolt Biotherapeutics, you can compare the effects of market volatilities on Cullinan Oncology and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Bolt Biotherapeutics.
Diversification Opportunities for Cullinan Oncology and Bolt Biotherapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cullinan and Bolt is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Bolt Biotherapeutics go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Bolt Biotherapeutics
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.98 times more return on investment than Bolt Biotherapeutics. However, Cullinan Oncology LLC is 1.02 times less risky than Bolt Biotherapeutics. It trades about 0.15 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.16 per unit of risk. If you would invest 1,668 in Cullinan Oncology LLC on March 5, 2024 and sell it today you would earn a total of 682.00 from holding Cullinan Oncology LLC or generate 40.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Cullinan Oncology LLC vs. Bolt Biotherapeutics
Performance |
Timeline |
Cullinan Oncology LLC |
Bolt Biotherapeutics |
Cullinan Oncology and Bolt Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cullinan Oncology and Bolt Biotherapeutics
The main advantage of trading using opposite Cullinan Oncology and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra TherapeuticsInc | Cullinan Oncology vs. Autolus Therapeutics |
Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stocks Directory Find actively traded stocks across global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |